Pierrel Logo

Pierrel

Pharmaceutical firm specializing in dental anesthetics and contract manufacturing.

PRL | XMIL

Overview

Corporate Details

ISIN(s):
IT0005549644
LEI:
8156002BC7CB6E3BD403
Country:
Italy
Address:
STRADA STATALE APPIA 7 BIS, 46/48, 81043 CAPUA

Description

Pierrel is a global pharmaceutical company specializing in oral health. With over 70 years of experience, the company focuses on the development, production, registration, and licensing of dental anesthetics and complementary medical devices. Its core expertise lies in the aseptic manufacturing of injectable drugs. The product portfolio includes a wide range of dental anesthetics marketed under its own brands, such as Orabloc®, Ubisestin™, Xylestesin™, and Mepivastesin™. In addition to its branded products, Pierrel offers medical devices for oral pathology screening, prevention, and regeneration. The company also provides contract manufacturing services to the pharmaceutical and life science industries. Its production facilities are authorized by major global regulatory agencies, including the EMA and FDA, ensuring compliance with high international quality standards.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2021-03-05 14:43
Pierrel S.p.A.: Aggiornamento calendario eventi societari
Italian 155.2 KB
2021-03-04 10:00
Pierrel S.p.A.: PIERREL RICEVE L’AUTORIZZAZIONE PER IL COMMERCIO DI ORABLOC® IN…
Italian 188.9 KB
2021-03-01 16:23
Pierrel S.p.A.: PIERREL RICEVE L’AUTORIZZAZIONE PER IL COMMERCIO DI ORABLOC® IN…
Italian 195.4 KB
2021-02-25 16:33
Pierrel S.p.A.: ORABLOC® DI PIERREL BATTE LA PANDEMIA E CONTINUA A SCALARE LE C…
Italian 272.8 KB
2021-02-08 15:02
Pierrel S.p.A.: PIERREL ANNUNCIA LA COMMERCIALIZZAZIONE DI ORABLOC NEEDLESTICK …
Italian 173.0 KB
2020-12-23 13:00
Pierrel S.p.A.: APPROVATO IL CALENDARIO DEGLI EVENTI SOCIETARI PER L’ESERCIZIO …
Italian 163.0 KB
2020-11-11 19:05
Pierrel S.p.A.: APPROVATO SU BASE VOLONTARIA IL RESOCONTO INTERMEDIO DI GESTION…
Italian 477.6 KB
2020-10-13 12:36
Pierrel S.p.A.: Aggiornamento calendario eventi societari
Italian 153.3 KB
2020-09-25 16:36
Pierrel S.p.A.: PIERREL RICEVE L’AUTORIZZAZIONE PER IL COMMERCIO DI ORABLOC® IN…
Italian 190.0 KB
2020-09-18 00:11
PIERREL S.P.A.: PUBBLICATA LA RELAZIONE FINANZIARIA SEMESTRALE DEL GRUPPO PIERR…
Italian 164.4 KB
2020-09-16 19:04
Pierrel S.p.A.: IL CDA APPROVA LA RELAZIONE FINANZIARIA SEMESTRALE DEL GRUPPO P…
Italian 485.4 KB
2020-09-11 12:17
Pierrel S.p.A.: Aggiornamento calendario eventi societari
Italian 154.8 KB
2020-07-22 17:03
Pierrel S.p.A.: Aggiornamento calendario eventi societari
Italian 146.7 KB
2020-06-17 09:04
Pierrel S.p.A.: PIERREL RICEVE L’AUTORIZZAZIONE PER IL COMMERCIO DI ORABLOC® IN…
Italian 155.7 KB
2020-05-14 19:37
Pierrel S.p.A.: APPROVATO SU BASE VOLONTARIA IL RESOCONTO INTERMEDIO DI GESTION…
Italian 422.4 KB

Automate Your Workflow. Get a real-time feed of all Pierrel filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Pierrel

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Pierrel via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Cardiol Therapeutics Inc. Logo
Clinical-stage company developing anti-inflammatory and anti-fibrotic heart therapies.
United States of America
CRDL
CAREGEN CO.,LTD. Logo
Develops biomimetic peptides and growth factors for aesthetic and medical solutions.
South Korea
214370
Caribou Biosciences, Inc. Logo
Clinical-stage biopharma developing genome-edited allogeneic cell therapies.
United States of America
CRBU
Carisma Therapeutics Inc. Logo
A clinical-stage biotech developing engineered macrophage-based therapeutics for cancer.
United States of America
CARM
Carna Biosciences, Inc. Logo
Clinical-stage biopharma developing small molecule kinase inhibitors.
Japan
4572
Cartesian Therapeutics, Inc. Logo
A clinical-stage company developing mRNA-engineered cell therapies for autoimmune diseases.
United States of America
RNAC
CASI Pharmaceuticals, Inc. Logo
Biopharmaceutical firm developing therapeutics for organ transplant and autoimmune diseases.
United States of America
CASI
CATALYST PHARMACEUTICALS, INC. Logo
Biopharmaceutical company commercializing drugs for rare neurological and autoimmune diseases.
United States of America
CPRX
cbdMD, Inc. Logo
Producer and distributor of health and wellness CBD products from U.S.-grown hemp.
United States of America
YCBD
CDT Equity Inc. Logo
A clinical-stage biopharmaceutical firm advancing assets for unmet medical needs.
United States of America
CDT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.